SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnology✕
Previous Page678910111213Next Page
2026-03-17ADAG3Adagene Inc. Insider Trading ReportMEDIUM
This filing details stock options granted to Ulf Grawunder, a director at Adagene Inc. Two grants of nonqualified stock options are reported: 40,000 options with an exercise price of $2.26, granted on April 8, 2024, vesting 50% on each of the first two anniversaries. Additionally, 25,000 options with an exercise price ...
Micro CapBiotechnology
Previous Page678910111213Next Page